
BMED focuses on total return by investing in the broad health sciences group of industries from R&D to production and distribution of medical supplies in different fields, including dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those providing related administrative, management or financial support. The fund reaches into non-human health (e.g., survival of plants and animals) such as firms that increase crop yields, taste, nutritional content or improve pet health. BMED will include firms with varying market-cap with…
Is BMED's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Longevity is, increasingly, a big business. Advances in healthcare technology and AI have prompted both prominent medical professionals and individual investors to imagine how people might live longer, healthier lives.

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

What to consider for thematic ETFs in 2022 and beyond.

'MDEV' is the first ETF focused solely on global medical device makers.